Integrated Medical Systems, Inc. (IMS) is the leading innovator in the development of fully integrated products for critical care. Our firm, whose principal shareholders include Northrop Grumman Corporation (NGC), is committed to the rapid deployment of products that include portable intensive care systems, advanced diagnostic and therapeutic devices, telemedicine networks, and related information systems. From our Northrop Grumman heritage, we bring the expertise of systems integration: the art and science of combining otherwise discrete devices, data systems and utilities into a single product, with the benefits of reduced weight, volume, cost and clutter; and increased safety, ease-of-use and reliability.
The LSTAT patient care platform represents a revolutionary advance in integrated medical-data-utility systems focused on improving clinical and economic outcome.
The FDA-cleared
LS-1™ "suitcase intensive care unit" facilitates 'real telemedicine'
by equipping caregivers with the ability to remotely control the
diagnostic and therapeutic devices integrated into this
next-generation system.
IMS is headquartered in Southern California, home to 20% of the nation's medical device industry and a region that leads the nation in the number of new medical device companies and products.
